These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 39216198)

  • 1. Racialized environments and syringe services program implementation: County-level factors.
    Bluthenthal RN; Humphrey JL; Strack CN; Wenger LD; LaKosky P; Patel SV; Kral AH; Lambdin B
    Drug Alcohol Depend; 2024 Oct; 263():112430. PubMed ID: 39216198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdose Education and Naloxone Distribution Within Syringe Service Programs - United States, 2019.
    Lambdin BH; Bluthenthal RN; Wenger LD; Wheeler E; Garner B; Lakosky P; Kral AH
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(33):1117-1121. PubMed ID: 32817603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.
    Jones AA; Park JN; Allen ST; Schneider KE; Weir BW; Hunt D; Sherman SG
    J Subst Abuse Treat; 2021 Oct; 129():108412. PubMed ID: 34080560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial.
    Lambdin BH; Bluthenthal RN; Garner BR; Wenger LD; Browne EN; Morris T; Ongais L; Megerian CE; Kral AH
    Implement Sci; 2024 Feb; 19(1):22. PubMed ID: 38419058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
    Arendt D
    J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Funding and Delivery of Syringe Services Programs in the United States, 2022.
    Facente SN; Humphrey JL; Akiba C; Patel SV; Wenger LD; Tookes H; Bluthenthal RN; LaKosky P; Prohaska S; Morris T; Kral AH; Lambdin BH
    Am J Public Health; 2024 Apr; 114(4):435-443. PubMed ID: 38478864
    [No Abstract]   [Full Text] [Related]  

  • 10. How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study.
    Lambdin BH; Wenger L; Bluthenthal R; Bartholomew TS; Tookes HE; LaKosky P; O'Neill S; Kral AH
    Harm Reduct J; 2023 Feb; 20(1):26. PubMed ID: 36855181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating equity in community-based naloxone access among racial/ethnic groups in Massachusetts.
    Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Linas BP; Morgan JR; Murphy SM; Walley AY; Schackman BR; Marshall BDL
    Drug Alcohol Depend; 2022 Dec; 241():109668. PubMed ID: 36309001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Structural Barriers and Racial Group Disparities of COVID-19 Mortality With Spatial Analysis.
    Lin Q; Paykin S; Halpern D; Martinez-Cardoso A; Kolak M
    JAMA Netw Open; 2022 Mar; 5(3):e220984. PubMed ID: 35244703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
    Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
    Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
    Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
    Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
    Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
    Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.
    Goedel WC; Shapiro A; Cerdá M; Tsai JW; Hadland SE; Marshall BDL
    JAMA Netw Open; 2020 Apr; 3(4):e203711. PubMed ID: 32320038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital admissions among people who inject opioids following syringe services program implementation.
    Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
    Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial.
    Akiba CF; Patel SV; Wenger LD; Morgan-Lopez A; Zarkin GA; Orme S; Davidson PJ; Kral AH; Lambdin BH
    Implement Sci; 2023 Aug; 18(1):33. PubMed ID: 37537665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inequities in naloxone administration among fatal overdose decedents by race and ethnicity in Pennsylvania, 2019-21.
    Takemoto E; Bolton A; Goetz CT
    Addiction; 2024 Aug; 119(8):1400-1409. PubMed ID: 38808397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.